Synthetic Biology Market Analysis

Application (Non-healthcare, Healthcare)

The global synthetic biology market is segmented and analyzed for demand and supply by application into non-healthcare, and healthcare. Out of the two types of applications, the healthcare segment is estimated to gain the largest market share of about 60% in the year 2037. The growth of the segment can be accredited to the presence of large number of patients requiring treatment in the healthcare industry. The hospitals in the industry are also growing rapidly in number, which is estimated to positively influence the segmental growth. For instance, by the year 2022 there was noted to be approximately 6,100 hospitals in the United States. Hospitals provide a wide range of medical care. Physicians, called hospital doctors, typically specialize in internal medicine, pediatrics, or general practice. They have the knowledge to solve common problems and the resources to solve more complex medical problems. Hospitals may also offer specialized care, such as neurology, obstetrics and gynecology, and oncology. By definition of a hospital, a county hospital is typically a primary medical facility in a region with numerous intensive care and mobile beds for patients requiring long-term care. These factors are predicted to boost the growth of the market in the forecast period.

End-user (Genome Engineering, Bioinformatics)

The global synthetic biology market is also segmented and analyzed for demand and supply by end user into genome engineering, and bioinformatics. Amongst these two segments, the genome engineering segment is expected to garner a significant share of around 45% in the year 2037. The growth of the segment can be accredited to the advancements in genome editing technologies. The development of genome editing technologies such as CRISPR-Cas9, TALENs, and zinc-finger nucleases has revolutionized the field of genome engineering. These technologies enable precise and efficient editing of DNA, which has led to the development of new applications in areas such as agriculture, healthcare, and biotechnology. Genome engineering can be used to develop personalized medicines by modifying genes and cells. With the increasing focus on precision medicine, the demand for genome engineering is expected to grow in the coming years. Genome engineering can be used to develop crops with improved traits such as disease resistance, drought tolerance, and higher yields. The growing demand for sustainable agriculture and the need to feed a growing population is expected to drive the growth of genome engineering in the agriculture sector. Genome engineering can be used to correct genetic mutations that cause genetic disorders. With the increasing prevalence of genetic disorders, the demand for genome engineering is expected to grow in the healthcare sector.

Our in-depth analysis of the global market includes the following segments: